Michael Wood
LifeSci Advisors
Replay available
Milestone Pharmaceuticals Inc. (MIST) Q2 2026 Earnings Call
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joseph Oliveto
President and Chief Executive Officer
Lorenz Muller
Chief Commercial Officer
Athena Chin
Analyst, TD Cowen & Company
Ted Tenthoff
Analyst, Piper Sandler
Mohit Bansal
Analyst, Wells Fargo
Tiago Faust
Analyst, Raymond James
Brandon Folks
Analyst, H.C. Wainwright & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Milestone Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.736 Greetings. Welcome to the Milestone Pharma 2Q26 Earnings Conference Call. 00:00:05.736 -- 00:00:09.199 At this time, all participants are in a listen-only mode. 00:00:09.199 -- 00:00:12.662 A question and answer session will follow the formal presentation. 00:00:12.662 -- 00:00:16.946 If anyone should require operator assistance during the conference, please press star 00:00:16.946 -- 00:00:21.490 zero on your telephone keypad. Please note this conference is being recorded. 00:00:21.490 -- 00:00:25.434 I will now turn the conference over to Michael Wood from LifeSci Advisors. 00:00:25.434 -- 00:00:28.455 Thank you, Michael. You may begin. 00:00:28.713 -- 00:00:32.595 Thank you and good morning, everyone, and welcome to Milestone Pharmaceuticals' second 00:00:32.595 -- 00:00:38.098 quarter 2026 financial results and business update conference call. 00:00:38.098 -- 00:00:40.999 Earlier this morning, the company issued a press release providing an overview of its 00:00:40.999 -- 00:00:47.062 financial results for the quarter ended June 30th, 2026 and recent corporate highlights. 00:00:47.062 -- 00:00:50.584 The release can be accessed on the investors' media section of the company's website, 00:00:50.584 -- 00:00:52.584 milestonepharma.com. 00:00:53.477 -- 00:00:56.840 Before we begin, I would like to remind you that some of the information presented on 00:00:56.840 -- 00:01:01.725 this conference call contains forward-looking statements under the securities laws. 00:01:01.725 -- 00:01:05.449 These forward-looking statements involve substantial risks and uncertainties that could 00:01:05.449 -- 00:01:10.795 cause actual clinical programs, future results, progress timing, performances, 00:01:10.795 -- 00:01:15.640 or achievements to di...